Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - L.A.M. Pharmaceutical (OTC BB:LAMP.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Recent Events
Aug 20Price hit new 52-week low ($0.53)
Location
800 Sheppard Avenue West
Ontario M3H 6B4
North York, Canada
Phone: (416) 633-3004
Fax: (416) 633-2363
Employees (last reported count): 6
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 69%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
L.A.M. Pharmaceutical, Corp. seeks to develop, license, produce and sell novel and proprietary pharmaceuticals. L.A.M. has a proprietary drug delivery technology that involves the use of an original Ionic Polymer Matrix (IPM) for the purpose of delivering, enhancing and sustaining the action of certain established therapeutic agents. L.A.M. has developed a transdermal (through the skin) IPM drug designed to be used in topical form for the relief of arthritic pain and pain caused by related conditions (L.A.M.'s Diclofenac-IPM). L.A.M.'s Diclofenac-IPM is a therapeutic preparation containing 30 mg (milligrams) of diclofenac per ml (milliliter). This clear, aqueous and highly absorbent gel is applied to the skin adjacent to the affected area. Various uses for L.A.M.'s skin-care product include controlling body odors, relief of dryness and for moisturization.
More from Market Guide: Expanded Business Description

Financial Summary
L.A.M. Pharmaceutical Corp is engaged in the research and development of novel, proprietary, long lasting injectable drugs and delivery systems for transdermal and topical drugs. For the six months ended 6/30/01, revenues totaled $300 thousand vs. none. Net loss rose from $916 thousand to $2.6 million. Revenues reflect a licensing agreement with Ixora Biomedical Company, Inc. Higher loss reflects the expenses related to obtaining the equity line of credit.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
Joseph Slechta, 52Pres, COO, Director
Peter Rothbart, M.D., 61Treasurer, Director
Gary Nath, 54Sec., Director
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:LAMP.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Aug-2001
$0.53 
Recent Price$0.70 
52-Week High
on 30-Jan-2001
$6.437
Beta3.22 
Daily Volume (3-month avg)67.5K
Daily Volume (10-day avg)32.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
52-Week Change-86.0%
52-Week Change
relative to S&P500
-81.2%
Share-Related Items
Market Capitalization$10.0M
Shares Outstanding14.3M
Float4.40M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.06 
Earnings (ttm)-$0.51 
Earnings (mrq)-$0.06 
Sales (ttm)$0.02 
Cash (mrq)$0.06 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)29.79 
Income Statements
Sales (ttm)$300.0K
EBITDA (ttm)-$5.84M
Income available to common (ttm)-$6.44M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-304.54%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)1.05 
Debt/EquityN/A 
Total Cash (mrq)$928.0K
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.